Original Article

Results of Intravitreal Ranibizumab Treatment for Exudative Age-Related Macular Degeneration
  • Umut Karaca
  • Ali Hakan Durukan
  • Fazil Cüneyt Erdurman
  • Güngör Sobaci
  • Mehmet Zeki Bayraktar
Turk J Ophthalmol 2012; 42: 25-29 DOI: 10.4274/tjo.42.46036
Direct Treatment Costs of Neovascular Age-related Macular Degeneration and Comparison of Gained and/or Preserved Vision with Expenditure
  • Şeyda Yıldırım
  • Cezmi Akkın
  • Zafer Öztaş
  • Serhad Nalçacı
  • Filiz Afrashi
  • Jale Menteş
Turk J Ophthalmol 2018; 48: 27-32 DOI: 10.4274/tjo.44370 PMID:29576895
Evaluation of Aflibercept Treatment Responses in Eyes with Bevacizumab/Ranibizumab-resistant Wet Age-related Macular Degeneration
  • Tuncay Topal
  • Taner Kar
  • Yildiray Yildirim
  • Sercan Koray Sagdiç
  • Cihan Büyükavsar
  • Abdullah Kaya
  • Ali Ayata
  • Murat Sönmez
  • Melih Hamdi Ünal
Turk J Ophthalmol 2017; 47: 133-137 DOI: 10.4274/tjo.34735 PMID:28630787
A New Diagnostic Tool For The Detection of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration: Preferential Hyperacuity Perimetry - Original Article
  • Umut Asli Dinç
  • Melda Nursal Yenerel
  • Ebru Görgün
  • Murat Öncel
  • Demir Basar
Turk J Ophthalmol 2008; 38: 139-143
Photodynamic Therapy Versus Combined Photodynamic Therapy - Intravitreal Triamcinolone Acetonide in Treatment of Subretinal Neovascular Membrane Associated with Age-related Macular Degeneration - Original Article
  • Mehmet Çakir
  • Osman Çekiç
  • Nese Molla
  • Sükrü Bayraktar
  • Ömer Faruk Yilmaz
Turk J Ophthalmol 2008; 38: 144-151
Comparison of Ranibizumab and Pegabtanib Sodium Monotherapies in Terms of Rates of Stabilization After the First Three Doses
  • Nilüfer Koçak
  • Hüseyin Aslankara
  • Durgül Türüthan
  • Süleyman Kaynak
Turk J Ophthalmol 2012; 42: 211-215 DOI: 10.4274/tjo.42.42714
Clinical Features and Course of Patients with Peripheral Exudative Hemorrhagic Chorioretinopathy
  • Zafer Cebeci
  • Yasemin Dere
  • Serife Bayraktar
  • Samuray Tuncer
  • Nur Kir
Turk J Ophthalmol 2016; 46: 215-220 DOI: 10.4274/tjo.71354 PMID:28058163
Analysing the Progression Rates of Macular Lesions with Autofluorescence Imaging Modes in Dry Age-Related Macular Degeneration
  • Kenan Olcay
  • Akin Çakir
  • Murat Sönmez
  • Eyüp Düzgün
  • Yildiray Yildirim
Turk J Ophthalmol 2015; 45: 235-238 DOI: 10.4274/tjo.93276 PMID:27800240
Correlation Between Microperimetric Changes and Symptom Duration in Classic Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration - Original Article
  • Ömer Uysal
Turk J Ophthalmol 2008; 38: 330-335
Comparison of Efficacy Between anti-VEGF Agents Alone and in Combination with Photodynamic Therapy in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
  • Sunay Duman
  • Damla Ergintürk Acar
  • Güner Üney
  • Dicle Hazırolan
  • Mehmet Akif Acar
  • Nurten Ünlü
Turk J Ophthalmol 2010; 40: 343-348 DOI: 10.4274/tjo.40.343
Intravitreal Ranibizumab Therapy in Wet Type Macular Degeneration
  • Hüseyin Dündar
  • Hasan Altinkaynak
  • Can Kocasaraç
  • Leyla Hazar
  • Kemal Yüksel
Turk J Ophthalmol 2014; 44: 356-360 DOI: 10.4274/tjo.02418
Ocular Photodynamic Therapy Results in Age Related Macular Degeneration with Subfoveal Choroidal Neovascularisation - Original Article
  • Yavuz Bardak
  • Osman Çekiç
  • Sahin Tig
  • Fadime Kendir
Turk J Ophthalmol 2007; 37: 447-452

Review

The Choroid and Optical Coherence Tomography
  • Taha Sezer
  • Muhammet Altinisik
  • Ibrahim Arif Koytak
  • Mehmet Hakan Özdemir
Turk J Ophthalmol 2016; 46: 30-37 DOI: 10.4274/tjo.10693 PMID:27800255
Age-Related Macular Degeneration: Classification and Pathogenesis
  • Imren Akkoyun
Turk J Ophthalmol 2014; 44: 476-480 DOI: 10.4274/tjo.80008

Original Article

Factors Affecting Compliance to Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Age-Related Macular Degeneration
  • Onur Polat
  • Sibel Inan
  • Serkan Özcan
  • Mustafa Dogan
  • Tuncay Küsbeci
  • Güliz Fatma Yavas
  • Ümit Übeyt Inan
Turk J Ophthalmol 2017; 47: 205-210 DOI: 10.4274/tjo.28003 PMID:28845324